Premier Alternatives

GeneCapture

Huntsville, AL · Founded 2009 · Privately Held (backing)

Developer of a medical diagnostic device designed to detect and identify pathogens and to bring infection detection to the point of care. GeneCapture is based in Huntsville, AL and was founded in 2009. Its last reported valuation was $23.5 million in Sep 2021. It has raised $7.4 million across 2 recorded rounds; the latest was a $500,000 seed round in Nov 2024.

Last reported valuation
$23.5M
Oct 2026
Priced at
—
Total raised
$7.4M
Last round
Seed Round
Nov 2024
Cap table — not yet on record

GeneCapture's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GeneCapture with a free account
  • ·The complete investor list: 11 names
  • ·Watch GeneCapture: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about GeneCapture

Where does GeneCapture's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across GeneCapture's 2 recorded funding rounds.
GeneCapture Cap Table & Share Classes | Premier Alternatives